Cost-Effectiveness of 4CMenB Infant Vaccination in England: A Comprehensive Valuation Considering the Broad Impact of Serogroup B Invasive Meningococcal Disease
Ekkehard Beck, Johan Klint, M. Neine, Stéphanie Garcia, Kinga Meszaros
Topics & Concepts
MedicineMeningococcal diseaseVaccinationDiseaseCost effectivenessDisease burdenCost-effectiveness analysisEconomic evaluationPediatricsBurden of diseaseValuation (finance)Incidence (geometry)Environmental healthIntensive care medicineRisk analysis (engineering)ImmunologyPathologyNeisseria meningitidisBacteriaGeneticsFinancePhysicsEconomicsBiologyOpticsBacterial Infections and VaccinesPneumonia and Respiratory InfectionsVaccine Coverage and Hesitancy